
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 4.61538461538 | 1.3 | 1.45 | 1.2804 | 156069 | 1.32710303 | CS |
4 | 0.06 | 4.61538461538 | 1.3 | 1.45 | 1.21 | 165393 | 1.29914261 | CS |
12 | -0.185 | -11.9741100324 | 1.545 | 1.8207 | 1.12 | 203052 | 1.38224451 | CS |
26 | -0.61 | -30.9644670051 | 1.97 | 2.36 | 0.726041 | 427565 | 1.28636353 | CS |
52 | -1.38 | -50.3649635036 | 2.74 | 3.17 | 0.726041 | 312691 | 1.65293336 | CS |
156 | 0.03 | 2.25563909774 | 1.33 | 4.2684 | 0.726041 | 161953 | 1.82118175 | CS |
260 | -1.31 | -49.063670412 | 2.67 | 5.7 | 0.726041 | 404309 | 2.78629331 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions